Results from a type two hybrid-effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Delaforce, Alana
Farmer, Shannon
Duff, Jed
Munday, Judy
Miller, Kristin
Glover, Lynne
Corney, Chris
Ansell, Gareth
Gutta, Naadir
Tuffaha, Haitham
Hardy, Janet
Hurst, Cameron
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2023
Size
File type(s)
Location
Abstract

Background Implementation of pathways to screen surgical patients for preoperative anemia and iron deficiency remains limited. This study sought to measure the impact of a theoretically informed, bespoke change package on improving the uptake of a Preoperative Anemia and Iron Deficiency Screening, Evaluation, and Management Pathway.

Study Design and Methods Pre-post interventional study using a type two hybrid-effectiveness design evaluated implementation. Four hundred (400) patient medical record reviews provided the dataset (200 pre- and 200-post implementation). The primary outcome measure was compliance with the pathway. Secondary outcome measures (clinical outcomes) were anemia on day of surgery, exposure to a red blood cell (RBC) transfusion, and hospital length of stay. Validated surveys facilitated data collection of implementation measures. Propensity score-adjusted analyses determined the effect of the intervention on clinical outcomes, and a cost analysis determined the economic impact.

Results For the primary outcome, compliance improved significantly post-implementation (Odds Ratio 10.6 [95% CI 4.4–25.5] p < .000). In secondary outcomes, adjusted analyses point estimates showed clinical outcomes were slightly improved for anemia on day of surgery (Odds Ratio 0.792 [95% CI 0.5–1.3] p = .32), RBC transfusion (Odds Ratio 0.86 [95% CI 0.41–1.78] p = .69) and hospital length of stay (Hazard Ratio 0.96 [95% CI 0.77–1.18] p = .67), although these were not statistically significant. Cost savings of $13,340 per patient were realized. Implementation outcomes were favorable for acceptability, appropriateness, and feasibility.

Conclusion The change package significantly improved compliance. The absence of a statistically significant change in clinical outcomes may be because the study was powered to detect an improvement in compliance only. Further prospective studies with larger samples are needed. Cost savings of $13,340 per patient were achieved and the change package was viewed favorably.

Journal Title

Transfusion

Conference Title
Book Title
Edition
Volume

63

Issue

4

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2023 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Item Access Status
Note
Access the data
Related item(s)
Subject

Cardiovascular medicine and haematology

Clinical sciences

Immunology

Science & Technology

Life Sciences & Biomedicine

Hematology

blood management

RBC transfusion

Persistent link to this record
Citation

Delaforce, A; Farmer, S; Duff, J; Munday, J; Miller, K; Glover, L; Corney, C; Ansell, G; Gutta, N; Tuffaha, H; Hardy, J; Hurst, C, Results from a type two hybrid-effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway, Transfusion, 2023, 63 (4), pp. 724-736

Collections